| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Total Income - EUR | - | - | - | - | - | - | 0 | 0 | 0 | 18.332 |
| Total Expenses - EUR | - | - | - | - | - | - | 1.394 | 3.413 | 7.229 | 22.143 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -1.394 | -3.413 | -7.229 | -3.810 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -1.394 | -3.413 | -7.229 | -3.810 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Alpha Sun Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 0 | 45.058 | 40.331 |
| Current Assets | - | - | - | - | - | - | 328 | 345 | 2.858 | 5.062 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 0 | 0 | 323 | 321 |
| Cash | - | - | - | - | - | - | 328 | 345 | 2.536 | 4.742 |
| Shareholders Funds | - | - | - | - | - | - | -1.354 | -4.771 | -11.985 | -15.729 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 1.682 | 5.116 | 59.902 | 39.248 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 21.874 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2511 - 2511" | |||||||||
| CAEN Financial Year |
2110
|
|||||||||
Comments - Alpha Sun Pharma S.r.l.